WHY THE COMBO IS BETTER THAN EITHER ALONE When GLP-1 therapy and truSculpt are combined, the results complement each other beautifully
BPC-157 increases the proliferation of fibroblast, plus it upregulates the gene expression responsible for the production of actin [1]
If you're also being treated for diabetes, thyroid issues, or heart disease, a weight-loss-only clinic often isn't talking to those other providers
If you are taking both semaglutide and an SGLT-2 inhibitor, which some diabetes management protocols include, the UTI risk from the SGLT-2 component deserves attention
GLP-1 medications are intriguing from a cancer research perspective because they werent designed for cancer therapy, but they do affect many different targets and pathways associated with cancer development, so were eager to study them in this context, McDonald says